Bengaluru: The U.S. Food and Drug Administration (USFDA) top vaccine official, Vinay Prasad, has been appointed as the agency ...

Vinay Prasad—the controversial head of vaccine regulation at the US Food and Drug Administration (FDA)—has been named FDA chief medical and scientific officer.1 Traditionally separate roles, his new ...

The U.S. Food and Drug Administration (USFDA) has announced that it has eliminated the Risk Evaluation and Mitigation ...

Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...

Commissioner Marty Makary and his new vaccines chief boxed longtime bureaucrats out of the recent decision to require more ...

FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

FDA Taps Vaxxer Skeptic Vinay Prasad To Oversee Vaccine, Gene Therapy ... and critic of pharmaceutical industry practices—as the new head of its Center for Biologics Evaluation and Research, ...

Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said the agency’s new risk-based COVID-19 vaccine framework contradicts the ...

Capricor's DMD therapy Deramiocel is under FDA Priority Review with no major issues flagged; PDUFA date set for August 31, 2025.

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named as director of the FDA's Center for Biologics Evaluation and Research ...